Balanced news tone
News Sentiment
000100 sentiment intelligence
Yuhan Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
13 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-2.7% over one week, -11.3% over four weeks, trend inactive, and below fair value.
Yuhan stock holds ground as earnings and pipeline shape valuation
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
-2.7%
Price reacting lower
Trend fit
Trend inactive
-11.3% over four weeks
Fair value
-29.4%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
13
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
ad-hoc-news.de
Direct company coverage
Yuhan stock holds ground as earnings and pipeline shape valuation
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jul 2026 15:45
- Source
- ad-hoc-news.de
TradingView
Direct company coverage
ETFs Investing in Yuhan Corporation Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 04:46
- Source
- TradingView
ad-hoc-news.de
Direct company coverage
Yuhan stock tracks its core pharma business
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 07:00
- Source
- ad-hoc-news.de
Chosunbiz
Direct company coverage
Yuhan honors Yu Il-han, pioneer of Korea’s employee ownership and philanthropy - CHOSUNBIZ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Mar 2026 07:00
- Source
- Chosunbiz
Chosunbiz
Direct company coverage
Yuhan hesitation over ImmuneOncia rights offering fuels Korea biotech backlash - CHOSUNBIZ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2026 08:00
- Source
- Chosunbiz
매일경제
Direct company coverage
Kimberly Clark, a global personal goods manufacturing company that is a major shareholder of Yuhan K..
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Aug 2025 07:00
- Source
- 매일경제
매일경제
Direct company coverage
Global personal product manufacturer Kimberly-Clark, the majority shareholder of Yuhan Kimberly, is
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Aug 2025 07:00
- Source
- 매일경제
koreabiomed.com
Direct company coverage
Yuhan’s biotech arm ImmuneOncia soars 108% in IPO on rare cancer strategy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2025 07:00
- Source
- koreabiomed.com
BioWorld News
Direct company coverage
MASH field still hot as Boehringer axes $870M deal with Yuhan
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 11 Mar 2025 07:00
- Source
- BioWorld News
koreabiomed.com
Direct company coverage
Yuhan sets ambitious targets for annual licensing deals, 30% shareholder return by 2027
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Oct 2024 07:00
- Source
- koreabiomed.com
Fierce Pharma
Direct company coverage
Gilead taps Korea's Yuhan to supply HIV drug ingredients in $81M deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 20 Sep 2024 07:00
- Source
- Fierce Pharma
koreabiomed.com
Direct company coverage
Yuhan's Leclaza becomes 1st Korean-made anti-cancer drug to score FDA nod
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Aug 2024 07:00
- Source
- koreabiomed.com
koreabiomed.com
Direct company coverage
[Top K-Pharma Analysis ⑤] Yuhan goes all-in in new drug R&D, despite profit decline
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 23 Feb 2023 08:00
- Source
- koreabiomed.com